Nestle India, the packaged foods maker behind Maggi, Nescafe and KitKat, heads into its Q2 FY 2026-2027 print after five straight quarters of double-digit volume growth and a Q1 where revenue rose 25.1% YoY. The quarter's big tests are whether the 24.2% EBITDA margin holds against a sharp run-up in cocoa, sugar and edible oil costs, and whether the nutrition (MPN) portfolio's return to volume growth sustains.
| Results date | October 15, 2026 |
|---|---|
| Quarter | Q2 FY 2026-2027 |
| Previous quarter revenue | Rs. 6,378.18 Cr |
| Previous quarter PAT | Rs. 975.12 Cr |
| Previous quarter EBITDA margin | 24.2% |
| Market cap | Rs. 257,044.3 Cr |
| CMP | Rs. 1,333.0 |
Nestle India Ltd (NESTLEIND) is scheduled to report its Q2 FY 2026-2027 results on October 15, 2026.
Alongside its Q1 FY27 results announced on 22 July 2026, the board declared a Special Dividend 2026 of Rs. 2.00 per share and the AGM-approved Final Dividend of Rs. 5.00 per share for FY 2025-26, together Rs. 7.00 per share (about Rs. 1,349.82 Cr), payable on and from 30 July 2026.
The key question for Q2 FY 2026-2027 is whether Nestle India can defend its Q1 EBITDA margin of 24.2% after cocoa rose about 17% over the quarter to roughly $6,569/MT by 1 September 2026, sugar spiked to about Rs. 65/kg before easing to Rs. 58.55/kg, and edible oils stayed about 20% higher YoY for most of the quarter. The company's roughly 96-day inventory buffer means part of Q2's cost of goods was bought at pre-spike prices, and the government's duty cut on crude palm and soybean oil (10% to 5%) effective 24 September only benefits the last week of the quarter, with the fuller impact expected in Q3. On demand, gross GST collections accelerated through the quarter from +4.5% YoY in July to +6.1% in September, while food inflation at 5.95% in August remains a watchout for price-sensitive categories; Nestle's own double-digit volume streak now spans five consecutive quarters through Q1 FY27, against an FMCG sector where volumes declined 2% YoY in the April-June period. Two Q1 one-offs complicate the PAT comparison: other income of Rs. 22.5 Cr versus Rs. 1.6 Cr in the year-ago quarter creates a roughly Rs. 17-18 Cr YoY headwind if it normalises, and the Rs. 6.2 Cr severance exceptional is not expected to recur. Management has guided only qualitatively — CFO Edouard Mac Nab, effective 1 March 2026, has said the company will 'maintain our margin in line with our past track record' — so the call will be watched for any restatement of the margin framework or introduction of quantified targets.
Margin guidance vs commodity pressure: Management's open-ended margin guidance faces its first real test with three commodity headwinds intensifying through the quarter.
Volume growth streak and MPN trajectory: The double-digit volume run and the nutrition portfolio's recovery are the two KPIs to track.
Strategic and capex updates: Execution updates on the solar acquisition, premiumisation pipeline and capacity build-out.
Tax orders, FSSAI and one-off items: Pending regulatory follow-ups and whether Q1's one-off items normalise.
New CFO's margin framework: A potential narrative shift as the new finance leadership delivers its first full results cycle.
Management declined to give projections ('I am not getting into forward-looking projections or numbers') but pointed to deep penetration headroom — noodles at about 35-36% monthly penetration versus biscuits at nearly 100%, and in urban India Nestle is half of biscuits and much smaller than salty snacks. FY 2025-26 volume growth was 10.7%, a significant acceleration from the previous five-year CAGR of 4.2%.
CFO Edouard Mac Nab said the company is 'not chasing growth at the cost of margin' and will 'maintain our margin in line with our past track record', with the elevated ad spends funded by efficiency programs. Q1 FY27 EBITDA margin was 24.2%, with advertising up 40.6% YoY and cost of materials consumed down 210bps to 42.9% of sales.
The MPN portfolio had negative volume growth for four-five years, but management reported good volume growth in the last quarter and expressed confidence in future mid-to-high single-digit volume growth, citing R&D investment and efforts to provide mothers and doctors accurate nutritional information. Management said it 'sees no reason for this trend to change'.
Standalone PAT of Rs. 975.12 Cr rose 47.9% YoY on 25.1% revenue growth, but the print was aided by other income jumping to Rs. 224.7 Mn from Rs. 41.7 Mn and a low base. A Rs. 62.3 Mn exceptional charge for employee severance/restructuring was also booked in the quarter.